Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itopride vs Metoclopramide for Feeding Intolerance in Critically-ill Patients
NCT03698292Unknown
- Sponsor
- Ain Shams University
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of itopride in feeding intolerance (2 arms), sponsored by Ain Shams University. Primary endpoint: Gastric Residual Volume at 7 days. Status: unknown.
02
Drugs
itopride
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT03698292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698292.